Benzinga's Top #PreMarket Losers
December 28, 2015 at 08:28 AM EST
Chimerix Inc (NASDAQ: CMRX) shares dipped 74.70 percent to $9.00 following Phase 3 trial failure. Chimerix announced in a press ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |